# Indications and Outcomes of Video Capsule Endoscopy in Sub-Saharan Africa: A 5-Year Single-Center Experience in Nairobi, Kenya

**Authors:** Werimo Pascal Kuka, Gloria Wangechi Mugo, Emmanuel Benge Oluoch, Eric Mwenda Murunga, Nelson O. Onyango, Kofi Clarke

PMC · DOI: 10.1155/jotm/6495299 · Journal of Tropical Medicine · 2025-07-23

## TL;DR

This study examines the use and outcomes of video capsule endoscopy in Nairobi, Kenya, revealing common causes of gastrointestinal issues and diagnostic success rates.

## Contribution

The study provides insights into VCE use in sub-Saharan Africa, highlighting unique infectious causes of gastrointestinal bleeding.

## Key findings

- The most common indication for VCE was obscure gastrointestinal bleeding, with angiodysplasia being the primary cause.
- Infectious causes of bleeding, such as helminths and suspected intestinal tuberculosis, were unique to this African cohort.
- The diagnostic yield of VCE was 77.1%, with a low capsule retention rate of 2.8%.

## Abstract

Background: Utilization of video capsule endoscopy (VCE) for the evaluation of small bowel disease is limited in Africa. The predominant causes of gastrointestinal disease in this region are infectious, but the prevalence of inflammatory bowel disease and malignancies is rising. We sought to evaluate the indications and outcomes of VCE in sub-Saharan Africa.

Methods: We conducted a retrospective study at an outpatient gastroenterology center in Nairobi, Kenya. Data collected included demographics of the study population, procedure indication, prior investigations, findings, and complications of VCE. Descriptive statistics were used to analyze the results, and statistical analysis of association was performed using Fischer's exact test; a p value of less than 0.05 was considered significant.

Results: A total of 72 patients underwent VCE from January 2017 to April 2022. The mean age was 59.1 years (range: 15–91); 61.7% were males. A total of 97.2% of the patients had a preceding upper and lower endoscopy. The indications were obscure gastrointestinal bleeding (GIB) in 51.4%, anemia (15.5%), abdominal pain (25.4%), altered bowel habits (23.9%), weight loss (9.9%), and suspected Crohn's disease (7.0%). The overall diagnostic yield was 77.1% and included angiodysplasia (14%), duodenitis (10.7%), mass/polyps (8.9%), suspected intestinal tuberculosis (7.1%), and helminths (2.8%). Angiodysplasia was the most common cause of GIB, accounting for 35.3% and 35.0% of occult and overt bleeding, respectively. Capsule retention occurred in 2 patients (2.8%).

Conclusions: There are similarities in indications and preceding workup in our cohort compared to existing literature from Western and Asian countries. Infectious causes of GIB were unique to our study.

## Linked entities

- **Diseases:** inflammatory bowel disease (MONDO:0005265), Crohn's disease (MONDO:0005011), intestinal tuberculosis (MONDO:0001678)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** CHGA (chromogranin A) [NCBI Gene 1113] {aka CGA, PHE5, PHES}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** polyp (MESH:D011127), inflammatory bowel disease (MESH:D015212), diarrhea (MESH:D003967), fatigue (MESH:D005221), VCE (MESH:D002062), celiac disease (MESH:D002446), vascular anomaly (MESH:D020785), chronic GI blood loss (MESH:D016063), duodenitis (MESH:D004382), ileal ulcer (MESH:D007077), Anemia (MESH:D000740), gastrointestinal disease (MESH:D005767), gastrointestinal tuberculosis (MESH:D014385), ileitis (MESH:D007079), melena (MESH:D008551), malabsorption syndromes (MESH:D008286), gastroparesis (MESH:D018589), ulcer (MESH:D014456), mass (MESH:C536030), iron deficiency anemia (MESH:D018798), enteropathy (MESH:C538273), abdominal pain (MESH:D015746), weight loss (MESH:D015431), Gastritis (MESH:D005756), hematemesis (MESH:D006396), Angiodysplasia (MESH:D016888), Crohn's disease (MESH:D003424), Small bowel abnormalities (MESH:D007409), malignancies (MESH:D009369), TB (MESH:D014376), inflammatory lesions (MESH:D007249), infections (MESH:D007239), GIB (MESH:D006471), Infectious (MESH:D003141), GIST (MESH:D046152), intestinal helminthiasis (MESH:C531698), intestinal obstruction (MESH:D007415), colon ulcers (MESH:D003108), melanosis coli (MESH:D008548), intestinal dysmotility (MESH:D007410), constipation (MESH:D003248), bleeding (MESH:D006470), enteric TB (MESH:D004751)
- **Chemicals:** domperidone (MESH:D004294), polyethylene glycol (MESH:D011092), barium (MESH:D001464)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12310308/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12310308/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12310308/full.md

---
Source: https://tomesphere.com/paper/PMC12310308